Arkansas telehealth visits raise a familiar set of questions for physicians licensed elsewhere: what licensure pathway applies, whether a compact can shorten the process, and how DEA rules interact with anything Arkansas requires on top of them. None of these answers are static, which is part of why they are worth checking against current sources rather than memory.
Where licensure requirements come from
Generally speaking, the state where the patient is physically located governs which medical board has jurisdiction over a telehealth encounter. For a physician treating patients in Arkansas, that typically means obtaining some form of authorization recognized by Arkansas's licensing board, whether through a standard license application, a compact-based pathway, or another mechanism the board maintains for out-of-state practitioners.
Compact membership and eligibility
The IMLC exists to reduce duplicate paperwork for physicians who qualify and want to practice in multiple states. Eligibility criteria and participating states are not fixed permanently — states join, and in rare cases policies shift — so confirming Arkansas's current compact status, along with the eligibility requirements that would apply to a specific physician, is a reasonable first step before assuming a compact pathway is available.
See current Arkansas telehealth requirements →Controlled substance prescribing considerations
Prescribing controlled substances through telehealth sits at the intersection of federal DEA rules and state-specific restrictions. Federal flexibilities that were extended during recent years have an uncertain long-term status, and some states layer their own requirements on top, such as limiting certain drug schedules to established patient relationships. A physician prescribing into Arkansas generally needs to track both sets of rules rather than treating DEA registration alone as sufficient.
Practical steps for out-of-state practices
A reasonable working approach involves confirming licensure status before the first visit, monitoring compact and prescribing rule updates on a recurring basis, and documenting informed consent practices in line with whatever the state currently expects. This is less about a single approval and more about an ongoing process, particularly for practices serving patients across several states at once.
Where this typically goes wrong
Common missteps tend to involve assuming a home-state license automatically covers out-of-state telehealth visits, or assuming compact or prescribing rules that applied a year ago still hold today. Requirements vary by state and change over time — always confirm current requirements directly with the relevant state board or agency before making a compliance decision.